Combined Use of Pulsed Dye Laser and Topical Antiangiogenic Agents for Treatment of Port Wine Stain Birthmarks

• Status: Withdrawn
• Trial end date: 2011-09-01
• Target enrollment: 0
• Participant gender: All

Summary

The researcher want to improve port wine stain (PWS) therapeutic outcome in response to laser therapy. The researcher want to determine whether the combined use of pulsed dye laser (PDL) therapy and topical tacrolimus or pimecrolimus will improve PWS therapeutic outcome.

• Phase: Phase 1/Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of California, Irvine
• Collaborator: Beckman Laser Institute University of California Irvine
• Treatments: Angiogenesis Inhibitors

Criteria

Inclusion Criteria:

• 16 years of age and older

• Have PWS suitable for comparison testing as determined by the study doctor

Exclusion Criteria:

• Less than 16 years old

• Are pregnant

• Have skin cancer

• Currently taking immunosuppressive or steroids or photosensitizing drugs

• Current participation in any other investigational drug evaluation

• Concurrent use of known photosensitizing drugs